Articles Tagged With:
-
Bexagliflozin Tablets (Brenzavvy)
Bexagliflozin can be prescribed as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
-
Biden Administration Pushes for Skilled Nursing Facility Ownership Transparency
A CMS proposal calls for stricter enforcement of an existing rule tucked into the Affordable Care Act.
-
Surgical Risk of Mitral Valve Repair, Updated
A contemporary update of the Society of Thoracic Surgeons risk calculator for operative mortality and morbidity in nonemergent primary mitral valve repair for regurgitation shows an operative mortality rate of 1.2%, with a conversion to replacement of 6%, in more than 53,000 patients.
-
ECMO-Supported CPR Disappoints for Treating Out-of-Hospital Cardiac Arrest
For patients with out-of-hospital cardiac arrest that was refractory to initial resuscitation efforts, adding extracorporeal membrane oxygenation to standard CPR did not result in a significant improvement in survival with favorable neurologic outcome.
-
How to Diagnose ATTR Cardiac Amyloidosis
A retrospective study of patients with confirmed cardiac amyloidosis showed negative light chain biomarkers and a typical pattern of cardiac amyloid on cardiac MRI was highly specific for the diagnosis of the transthyretin subtype and may obviate the need for further testing before starting treatment.
-
Long-Term Maintenance Therapy After Percutaneous Coronary Intervention
An extended six-year follow-up of the HOST-EXAM study revealed the consistent benefit of the primary endpoint of fewer major cardiovascular events and less bleeding with clopidogrel vs. low-dose aspirin monotherapy in post-percutaneous coronary intervention patients who were on dual antiplatelet therapy for one year.
-
Effectiveness of Dietary Supplements on Lipid and Inflammatory Biomarkers
In a comparison of rosuvastatin 5 mg/day, six common dietary supplements marketed for improving heart health, and placebo, none reduced high-sensitivity C-reactive protein levels. Only rosuvastatin significantly reduced LDL cholesterol levels compared to placebo.
-
Novel Bedside Procedure Improves Tracheostomy Outcomes
Nurse-driven initiative led to zero incidents of tracheostomy medical device-related pressure injuries for three years.
-
OCR Strengthens Confidentiality of Substance Use Disorder Patient Records
The Office for Civil Rights and the Substance Abuse and Mental Health Services Administration recently announced proposed changes to the Confidentiality of Substance Use Disorder Patient Records under 42 CFR Part 2, which could affect HIPAA compliance programs.
-
Tracking Software Can Lead to HIPAA Violations
The HHS Office for Civil Rights has released a bulletin warning the use of website tracking technologies could result in HIPAA violations. Covered entities need to review their use of these tracking technologies and make necessary improvements.